Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis

Zimmermann D, Guthohrlein EW, Malesevic M, Sewald K, Wobbe L, Heggemann C, Sewald N (2005)
CHEMBIOCHEM 6(2): 272-276.

Download
Es wurde kein Volltext hochgeladen. Nur Publikationsnachweis!
Zeitschriftenaufsatz | Veröffentlicht | Englisch
Autor
; ; ; ; ; ;
Erscheinungsjahr
Zeitschriftentitel
CHEMBIOCHEM
Band
6
Zeitschriftennummer
2
Seite
272-276
ISSN
PUB-ID

Zitieren

Zimmermann D, Guthohrlein EW, Malesevic M, et al. Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis. CHEMBIOCHEM. 2005;6(2):272-276.
Zimmermann, D., Guthohrlein, E. W., Malesevic, M., Sewald, K., Wobbe, L., Heggemann, C., & Sewald, N. (2005). Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis. CHEMBIOCHEM, 6(2), 272-276. doi:10.1002/cbic.200400279
Zimmermann, D., Guthohrlein, E. W., Malesevic, M., Sewald, K., Wobbe, L., Heggemann, C., and Sewald, N. (2005). Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis. CHEMBIOCHEM 6, 272-276.
Zimmermann, D., et al., 2005. Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis. CHEMBIOCHEM, 6(2), p 272-276.
D. Zimmermann, et al., “Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis”, CHEMBIOCHEM, vol. 6, 2005, pp. 272-276.
Zimmermann, D., Guthohrlein, E.W., Malesevic, M., Sewald, K., Wobbe, L., Heggemann, C., Sewald, N.: Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis. CHEMBIOCHEM. 6, 272-276 (2005).
Zimmermann, D, Guthohrlein, EW, Malesevic, M, Sewald, K, Wobbe, Lutz, Heggemann, C, and Sewald, Norbert. “Integrin alpha(5)beta(1) ligands: Biological evaluation and conformational analysis”. CHEMBIOCHEM 6.2 (2005): 272-276.

15 Zitationen in Europe PMC

Daten bereitgestellt von Europe PubMed Central.

Integrin Ligands with α/β-Hybrid Peptide Structure: Design, Bioactivity, and Conformational Aspects.
De Marco R, Tolomelli A, Juaristi E, Gentilucci L., Med Res Rev 36(3), 2016
PMID: 26777675
αvβ3- or α5β1-Integrin-Selective Peptidomimetics for Surface Coating.
Mas-Moruno C, Fraioli R, Rechenmacher F, Neubauer S, Kapp TG, Kessler H., Angew Chem Int Ed Engl 55(25), 2016
PMID: 27258759
The integrin ligand c(RGDf(NMe)Nal) reduces neointimal hyperplasia in a polymer-free drug-eluting stent system.
Rechenmacher F, Steigerwald K, Laufer B, Neubauer S, Kapp TG, Li L, Mas-Moruno C, Joner M, Kessler H., ChemMedChem 9(7), 2014
PMID: 24706601
HUVEC cell affinity evaluation and integrin-mediated mechanism study on PHSRN-modified polymer.
Liu Y, Wang W, Wang J, Yuan Z, Tang S, Liu M, Tang H., Colloids Surf B Biointerfaces 84(1), 2011
PMID: 21216133
Conformational control of integrin-subtype selectivity in isoDGR peptide motifs: a biological switch.
Frank AO, Otto E, Mas-Moruno C, Schiller HB, Marinelli L, Cosconati S, Bochen A, Vossmeyer D, Zahn G, Stragies R, Novellino E, Kessler H., Angew Chem Int Ed Engl 49(48), 2010
PMID: 20957712
Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent manner.
Jiménez-Soto LF, Kutter S, Sewald X, Ertl C, Weiss E, Kapp U, Rohde M, Pirch T, Jung K, Retta SF, Terradot L, Fischer W, Haas R., PLoS Pathog 5(12), 2009
PMID: 19997503
Conformational consequences of regio- and stereoselective disulfide bridge oxidation in a cyclic peptide.
Malesević M, Jahreis G, Wawra S, Fischer G, Lücke C., Chembiochem 9(1), 2008
PMID: 18072227
Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
Salvati M, Cordero FM, Pisaneschi F, Melani F, Gratteri P, Cini N, Bottoncetti A, Brandi A., Bioorg Med Chem 16(8), 2008
PMID: 18343671
The constrained amino acid beta-Acc confers potency and selectivity to integrin ligands.
Urman S, Gaus K, Yang Y, Strijowski U, Sewald N, De Pol S, Reiser O., Angew Chem Int Ed Engl 46(21), 2007
PMID: 17394270
Probing integrin selectivity: rational design of highly active and selective ligands for the alpha5beta1 and alphavbeta3 integrin receptor.
Heckmann D, Meyer A, Marinelli L, Zahn G, Stragies R, Kessler H., Angew Chem Int Ed Engl 46(19), 2007
PMID: 17394271
Synthesis, and structural and biological studies of efrapeptin C analogues.
Jost M, Weigelt S, Huber T, Majer Z, Greie JC, Altendorf K, Sewald N., Chem Biodivers 4(6), 2007
PMID: 17589859
Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds.
Benfatti F, Cardillo G, Fabbroni S, Galzerano P, Gentilucci L, Juris R, Tolomelli A, Baiula M, Spartà A, Spampinato S., Bioorg Med Chem 15(23), 2007
PMID: 17869121
Helicobacter exploits integrin for type IV secretion and kinase activation.
Kwok T, Zabler D, Urman S, Rohde M, Hartig R, Wessler S, Misselwitz R, Berger J, Sewald N, König W, Backert S., Nature 449(7164), 2007
PMID: 17943123
Survey of the year 2005 commercial optical biosensor literature.
Rich RL, Myszka DG., J Mol Recognit 19(6), 2006
PMID: 17125150

24 References

Daten bereitgestellt von Europe PubMed Central.


cardarelli, 1996

müller, lett pept sci 4(), 1997

mould, j biol chem 270(), 1995

nath, j cell biol 112(), 1999

haubner, 1994

xu, j biol chem 275(), 2000

vella, j biol chem 278(), 2003

pfaff, j biol chem 269(), 1994
Development and application of surface plasmon resonance-based biosensors for the detection of cell-ligand interactions.
Quinn JG, O'Neill S, Doyle A, McAtamney C, Diamond D, MacCraith BD, O'Kennedy R., Anal. Biochem. 281(2), 2000
PMID: 10870828
Kinetic analysis of the interaction between HIV-1 protease and inhibitors using optical biosensor technology.
Markgren PO, Hamalainen M, Danielson UH., Anal. Biochem. 279(1), 2000
PMID: 10683232
A regulated interaction between alpha5beta1 integrin and osteopontin.
Barry ST, Ludbrook SB, Murrison E, Horgan CM., Biochem. Biophys. Res. Commun. 267(3), 2000
PMID: 10673366
Are β-Amino Acids γ-Turn Mimetics? Exploring A New Design Principle for Bioactive Cyclopeptides
Schumann, Journal of the American Chemical Society 122(48), 2000
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen.
Nachman RL, Leung LL., J. Clin. Invest. 69(2), 1982
PMID: 6460044
Integrin Signaling and Matrix Assembly
Ruoslahti, Tumor Biology 17(2), 1996
BIAcore for macromolecular interaction.
Fivash M, Towler EM, Fisher RJ., Curr. Opin. Biotechnol. 9(1), 1998
PMID: 9503595
Receptor-bound conformation of an alpha(5)beta(1) integrin antagonist by (15)N-edited 2D transferred nuclear overhauser effects.
Zhang L, Mattern RH, Malaney TI, Pierschbacher MD, Goodman M., J. Am. Chem. Soc. 124(12), 2002
PMID: 11902863
MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures
Kraulis, Journal of Applied Crystallography 24(5), 1991
RGD and other recognition sequences for integrins.
Ruoslahti E., Annu. Rev. Cell Dev. Biol. 12(), 1996
PMID: 8970741
Stereoisomeric Peptide Libraries and Peptidomimetics for Designing Selective Inhibitors of theαvβ3 Integrin for a New Cancer Therapy
Haubner, Angewandte Chemie International Edition in English 36(1314), 1997
Methods for analysis of the integrin ligand binding event.
Smith JW., Methods Cell Biol. 69(), 2002
PMID: 12070996
Stereoisomere Peptid-Bibliotheken und Peptidmimetika zum Design von selektiven Inhibitoren des αv β3-Integrins für eine neuartige Krebstherapie
Haubner, Angewandte Chemie 109(13-14), 1997

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 15645521
PubMed | Europe PMC

Suchen in

Google Scholar